Author:
Layton Deborah,Shakir Saad A. W.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Toxicology
Reference24 articles.
1. European Medicines Agency (EMA). Guideline on good pharmacovigilance practices (GVP) module viii—post-authorisation safety studies (rev 1). EMA/813938/2011. London: EMA, 19 April 2013.
2. European Network of Centres of Excellence for Pharmacoepidemiology and Pharmacovigilance (ENCEPP). Guide on methodological standards in pharmacoepidemiology (revision 2). EMA/95098/2010. London: ENCEPP, 18 June 2013.
3. Layton D, Hazell L, Shakir SA. Modified prescription-event monitoring studies: a tool for pharmacovigilance and risk management. Drug Saf. 2011.
4. Layton D, Shakir SAW. Prescription-event monitoring. In: Strom BL, Kimmel SE, Hennessy S, editors. Pharmacoepidemiology, 5th edn. Chichester, UK: John Wiley & Sons Ltd; 2011. p. 301–330.
5. Suissa S. Immortal time bias in observational studies of drug effects. Pharmacoepidemiol Drug Saf. 2007;16(3):241–9.
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献